as on January 17, 2026 at 2:29 am IST
Day's Low
Day's High
1.03%
Downside
3.15%
Upside
52 Week's Low
52 Week's High
21.55%
Downside
101.39%
Upside
Check NovoCure Limited market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.5B
EPS (TTM)
-1.39
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.06%
PE Ratio (TTM)
-12.67
Industry PE ratio
6.809270833333334
PEG Ratio
-0.47
EBITDA
-159.3M
Revenue (TTM)
642.3M
Profit Margin
-27.66%
Return On Equity TTM
-50.60%
Track how NovoCure Limited P/E has moved over time to understand its valuation trends.
NovoCure Limited in the last 5 years
Lowest (-179.24x)
December 31, 2021
Today (-12.67x)
January 17, 2026
Industry (6.81x)
January 17, 2026
Highest (-6.86x)
December 31, 2023
Today’s Price to Earnings Ratio: -12.67x
Compare market cap, revenue, PE, and other key metrics of NovoCure Limited with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.5B | -91.86% | -12.67 | -27.66% | |
| BUY | $133.5B | 142.42% | 48.14 | 14.43% | |
| BUY | $138.6B | 50.33% | 47.63 | 12.07% | |
| BUY | $127.0B | -17.16% | 26.83 | 13.71% | |
| BUY | $215.0B | 9.4% | 15.52 | 31.88% |
The NovoCure Limited stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
NovoCure Limited investment value today
Current value as on today
₹56,840
Returns
Returns from NovoCure Limited Stock
Dollar Returns*
₹4,720 (+4.72%)
Based on 13 analysts
61.54%
Buy
38.46%
Hold
0.00%
Sell
Based on 13 analysts, 61.54% of analysts recommend a 'BUY' rating for NovoCure Limited. Average target price of $24.07
Get share price movements and forecasts by analysts on NovoCure Limited.
What analysts predicted
43.33%UPSIDE
Target Price
$24.07
Current Price
$13.64
Analyzed by
13 Analysts
Target
$24.07
NovoCure Limited target price $24.07, a slight upside of 43.33% compared to current price of $13.64. According to 13 analysts rating.
Search interest for NovoCure Limited Stock has increased by 56% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:56% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 154.99M → 167.20M (in $), with an average increase of 3.7% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -40.13M → -37.27M (in $), with an average increase of 7.7% per quarter
Against Peers
![]()
In the last 1 year, Edwards Lifesciences Corp. has given 20.9% return, outperforming this stock by 68.8%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 7.0% return, outperforming this stock by 92.2%
Price Dip
![]()
In the last 3 years, NVCR stock has moved down by -85.2%
| Organisation | NovoCure Limited |
| Headquarters | Neuhofstrasse 21, Baar, Switzerland, 6340 |
| Industry | Health Technology |
| CEO | Mr. Frank Leonard |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Frank Leonard | Chief Executive Officer |
Mr. Barak Ben-Arye | General Counsel |
Dr. Uri Weinberg M.D., Ph.D. | Chief Innovation Officer |
Dr. Nicolas Leupin M.B.A., M.D., Ph.D. | Chief Medical Officer |
Mr. William F. Doyle | Executive Chairman |
Mr. Christoph Brackmann | Chief Financial Officer |
Mr. Mukund Paravasthu | Chief Operating Officer |
Ms. Ingrid Goldberg | VP of Investor Relations |
Mr. Michael Puri | Chief Human Resources Officer |
NovoCure Limited share price today is $13.64 as on at the close of the market. NovoCure Limited share today touched a day high of $14.07 and a low of $13.5.
NovoCure Limited share touched a 52 week high of $27.47 on and a 52 week low of $10.7 on . NovoCure Limited stock price today i.e. is closed at $13.64,which is 50.35% down from its 52 week high and 27.48% up from its 52 week low.
NovoCure Limited market capitalisation is $0.00T as on .
Indian investors can start investing in NovoCure Limited (NVCR) shares with as little as ₹90.662 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.62 in NovoCure Limited stock (as per the Rupee-Dollar exchange rate as on ).
Based on NovoCure Limited share’s latest price of $13.64 as on January 17, 2026 at 2:29 am IST, you will get 0.7331 shares of NovoCure Limited. Learn more about
fractional shares .
NovoCure Limited stock has given -91.86% share price returns and 23.31% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?